Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Levomilnacipran> ?p ?o. }
Showing items 1 to 64 of
64
with 100 items per page.
- Levomilnacipran abstract "Levomilnacipran (brand name Fetzima, formerly known as F2695) is an antidepressant developed by Forest Laboratories and Pierre Fabre Group for the treatment of depression. As of 2009 it was in phase III clinical trials. Levomilnacipran is an active enantiomer of milnacipran and therefore has similar effects and pharmacology, acting as a serotonin-norepinephrine reuptake inhibitor.On 20 January 2011, Forest and Pierre Fabre Medicament announced that levomilnacipran was no better than placebo in a late-stage clinical trial. Two other late-stage trials will be finished in mid-2011. The FDA approved the product in July 2013.".
- Levomilnacipran atcPrefix "none".
- Levomilnacipran casNumber "96847-55-1".
- Levomilnacipran casSupplemental "175131-60-9 (hydrochloride)".
- Levomilnacipran fdaUniiCode "UGM0326TXX".
- Levomilnacipran iupacName "(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide".
- Levomilnacipran pubchem "6917779".
- Levomilnacipran thumbnail Levomilnacipran.svg?width=300.
- Levomilnacipran wikiPageID "26370510".
- Levomilnacipran wikiPageRevisionID "606733700".
- Levomilnacipran atcPrefix "none".
- Levomilnacipran bioavailability "92.0".
- Levomilnacipran c "15".
- Levomilnacipran casNumber "96847".
- Levomilnacipran casSupplemental "175131".
- Levomilnacipran chemspiderid "5293005".
- Levomilnacipran eliminationHalfLife "43200.0".
- Levomilnacipran excretion Kidney.
- Levomilnacipran h "22".
- Levomilnacipran hasPhotoCollection Levomilnacipran.
- Levomilnacipran inchi "1".
- Levomilnacipran inchikey "GJJFMKBJSRMPLA-DZGCQCFKBL".
- Levomilnacipran iupacName "-2".
- Levomilnacipran kegg "D10072".
- Levomilnacipran legalStatus "Rx-Only".
- Levomilnacipran metabolism "Hepatic".
- Levomilnacipran molecularWeight "246.348".
- Levomilnacipran n "2".
- Levomilnacipran o "1".
- Levomilnacipran proteinBound "22.0".
- Levomilnacipran pubchem "6917779".
- Levomilnacipran routesOfAdministration "Oral".
- Levomilnacipran smiles "CCNC[C@]1C2=CC=CC=C2".
- Levomilnacipran stdinchi "1".
- Levomilnacipran stdinchikey "GJJFMKBJSRMPLA-DZGCQCFKSA-N".
- Levomilnacipran unii "UGM0326TXX".
- Levomilnacipran verifiedfields "changed".
- Levomilnacipran verifiedrevid "451552762".
- Levomilnacipran watchedfields "changed".
- Levomilnacipran width "200".
- Levomilnacipran subject Category:Amides.
- Levomilnacipran subject Category:Enantiopure_drugs.
- Levomilnacipran subject Category:Serotonin-norepinephrine_reuptake_inhibitors.
- Levomilnacipran type Agent114778436.
- Levomilnacipran type CausalAgent100007347.
- Levomilnacipran type Drug103247620.
- Levomilnacipran type EnantiopureDrugs.
- Levomilnacipran type Inhibitor114724436.
- Levomilnacipran type Matter100020827.
- Levomilnacipran type PhysicalEntity100001930.
- Levomilnacipran type Serotonin-norepinephrineReuptakeInhibitors.
- Levomilnacipran type Substance100020090.
- Levomilnacipran type Drug.
- Levomilnacipran type DrugProduct.
- Levomilnacipran type FunctionalSubstance.
- Levomilnacipran comment "Levomilnacipran (brand name Fetzima, formerly known as F2695) is an antidepressant developed by Forest Laboratories and Pierre Fabre Group for the treatment of depression. As of 2009 it was in phase III clinical trials.".
- Levomilnacipran label "Levomilnacipran".
- Levomilnacipran sameAs m.0bbtt3h.
- Levomilnacipran sameAs Q6535779.
- Levomilnacipran sameAs Q6535779.
- Levomilnacipran sameAs Levomilnacipran.
- Levomilnacipran wasDerivedFrom Levomilnacipran?oldid=606733700.
- Levomilnacipran depiction Levomilnacipran.svg.
- Levomilnacipran isPrimaryTopicOf Levomilnacipran.